(Q44642214)

4 December 2017

title

Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS). (English)

1 reference

4 December 2017

main subject

coronary artery disease

1 reference

5

1 reference

4 December 2017

1

Michael G Shlipak

1 reference

4 December 2017

Lily A Chaput

2

1 reference

4 December 2017

Eric Vittinghoff

3

1 reference

4 December 2017

Feng Lin

4

1 reference

4 December 2017

Robert H Knopp

6

1 reference

4 December 2017

Stephen B Hulley

7

1 reference

4 December 2017

Heart and Estrogen/progestin Replacement Study Investigators

8

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

4 December 2017

published in

American Heart Journal

1 reference

4 December 2017

volume

146

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

870-875

1 reference

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Cholesterol reduction yields clinical benefit: impact of statin trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Effect of hormone replacement therapy on the validity of the Friedewald equation in postmenopausal women: the postmenopausal estrogen/progestins interventions (PEPI) trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Prediction of creatinine clearance from serum creatinine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

The effect of continuous combined hormone replacement therapy on arterial reactivity in postmenopausal women with established angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Estrogen-induced small low density lipoprotein particles may be atherogenic in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Different effects of continuous oestrogen-progestin and transdermal oestrogen with cyclic progestin regimens on low-density lipoprotein subclasses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

Oral 17beta-estradiol and medroxyprogesterone acetate therapy in postmenopausal women increases HDL particle size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900412-5

10.1016/S0002-8703(03)00412-5

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference